Precision Medicine

One company is working on cutting-edge technology that could change the way providers treat neurological diseases.

The work aims to personalize cancer care using a patient’s DNA.

[Correction: An earlier version of this article misstated that Bumrungrad launched the Foundation One CDx panel.

Australia’s national science agency CSIRO and GenesisCare, one of Australia’s largest cancer care providers, today announced a A$5.

Recursion releases more than 300 gigabytes of data it hopes will be a "playground" for innovative new machine learning applications.

Pinnacle Ventures has launched a pharmacogenomics programme to enable genetic testing to drive personalised prescribing decisions.

Earlier this week, the Western Australia (WA) Government announced the establishment of a new Ministerial Council that will advise the State Government on opportunities to further develop and support precision health advances.

Successful healthcare transformation depends on merging compliance with convenience in tools used by clinicians, says Elena Bonfiglioli, Microsoft's Managing Director of Health and Life Sciences for Europe, Middle East and Africa.

The project was showcased in the latest issue of the HIMSS Insights eBook, published at the beginning of April.

The teams will collect, process and analyze EHR data of up to 3,000 patients to create personalized care plans for people with MS.